Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Oncology Drug Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Chemotherapy
  • 1.3.3 Targeted Therapy
  • 1.3.4 Immunotherapy
  • 1.3.5 Hormonal Therapy
  • 1.3.6 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Oncology Drug Market Share by Application (2019-2025)
  • 1.4.2 Blood Cancer
  • 1.4.3 Breast Cancer
  • 1.4.4 gastrointestinal Tract Cancer
  • 1.4.5 Prostate Cancer
  • 1.4.6 Lung Cancer
  • 1.4.7 Skin Cancer
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Oncology Drug Market Size
  • 2.1.1 Global Oncology Drug Revenue 2014-2025
  • 2.1.2 Global Oncology Drug Sales 2014-2025
• 2.2 Oncology Drug Growth Rate by Regions
  • 2.2.1 Global Oncology Drug Sales by Regions 2014-2019
  • 2.2.2 Global Oncology Drug Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Oncology Drug Sales by Manufacturers
  • 3.1.1 Oncology Drug Sales by Manufacturers 2014-2019
  • 3.1.2 Oncology Drug Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Oncology Drug Revenue by Manufacturers (2014-2019)
  • 3.2.2 Oncology Drug Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Oncology Drug Market Concentration Ratio (CR5 and HHI)
• 3.3 Oncology Drug Price by Manufacturers
• 3.4 Key Manufacturers Oncology Drug Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Oncology Drug Market
• 3.6 Key Manufacturers Oncology Drug Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Chemotherapy Sales and Revenue (2014-2019)
  • 4.1.2 Targeted Therapy Sales and Revenue (2014-2019)
  • 4.1.3 Immunotherapy Sales and Revenue (2014-2019)
  • 4.1.4 Hormonal Therapy Sales and Revenue (2014-2019)
  • 4.1.5 Others Sales and Revenue (2014-2019)
• 4.2 Global Oncology Drug Sales Market Share by Type
• 4.3 Global Oncology Drug Revenue Market Share by Type
• 4.4 Oncology Drug Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Oncology Drug Sales by Application

6 United States

• 6.1 United States Oncology Drug Breakdown Data by Company
• 6.2 United States Oncology Drug Breakdown Data by Type
• 6.3 United States Oncology Drug Breakdown Data by Application

7 European Union

• 7.1 European Union Oncology Drug Breakdown Data by Company
• 7.2 European Union Oncology Drug Breakdown Data by Type
• 7.3 European Union Oncology Drug Breakdown Data by Application

8 China

• 8.1 China Oncology Drug Breakdown Data by Company
• 8.2 China Oncology Drug Breakdown Data by Type
• 8.3 China Oncology Drug Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Oncology Drug Breakdown Data by Company
• 9.2 Rest of World Oncology Drug Breakdown Data by Type
• 9.3 Rest of World Oncology Drug Breakdown Data by Application
• 9.4 Rest of World Oncology Drug Breakdown Data by Countries
  • 9.4.1 Rest of World Oncology Drug Sales by Countries
  • 9.4.2 Rest of World Oncology Drug Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Roche Ltd
  • 10.1.1 Roche Ltd Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Oncology Drug
  • 10.1.4 Oncology Drug Product Introduction
  • 10.1.5 Roche Ltd Recent Development
• 10.2 Novartis AG
  • 10.2.1 Novartis AG Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Oncology Drug
  • 10.2.4 Oncology Drug Product Introduction
  • 10.2.5 Novartis AG Recent Development
• 10.3 Bristol-Myers Squibb
  • 10.3.1 Bristol-Myers Squibb Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Oncology Drug
  • 10.3.4 Oncology Drug Product Introduction
  • 10.3.5 Bristol-Myers Squibb Recent Development
• 10.4 Celgene Corporation
  • 10.4.1 Celgene Corporation Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Oncology Drug
  • 10.4.4 Oncology Drug Product Introduction
  • 10.4.5 Celgene Corporation Recent Development
• 10.5 Johnson & Johnson
  • 10.5.1 Johnson & Johnson Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Oncology Drug
  • 10.5.4 Oncology Drug Product Introduction
  • 10.5.5 Johnson & Johnson Recent Development
• 10.6 Pfizer Inc.
  • 10.6.1 Pfizer Inc. Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Oncology Drug
  • 10.6.4 Oncology Drug Product Introduction
  • 10.6.5 Pfizer Inc. Recent Development
• 10.7 Astra Zenca Plc
  • 10.7.1 Astra Zenca Plc Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Oncology Drug
  • 10.7.4 Oncology Drug Product Introduction
  • 10.7.5 Astra Zenca Plc Recent Development
• 10.8 Eli Lilly And Company.
  • 10.8.1 Eli Lilly And Company. Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Oncology Drug
  • 10.8.4 Oncology Drug Product Introduction
  • 10.8.5 Eli Lilly And Company. Recent Development
• 10.9 Glaxosmithkline Plc
  • 10.9.1 Glaxosmithkline Plc Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Oncology Drug
  • 10.9.4 Oncology Drug Product Introduction
  • 10.9.5 Glaxosmithkline Plc Recent Development
• 10.10 Merck & Co.
  • 10.10.1 Merck & Co. Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Oncology Drug
  • 10.10.4 Oncology Drug Product Introduction
  • 10.10.5 Merck & Co. Recent Development
• 10.11 Sanofi
• 10.12 Amgen Inc.
• 10.13 Abbvie

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Oncology Drug Sales Channels
  • 11.2.2 Oncology Drug Distributors
• 11.3 Oncology Drug Customers

12 Market Forecast

• 12.1 Global Oncology Drug Sales and Revenue Forecast 2019-2025
• 12.2 Global Oncology Drug Sales Forecast by Type
• 12.3 Global Oncology Drug Sales Forecast by Application
• 12.4 Oncology Drug Forecast by Regions
  • 12.4.1 Global Oncology Drug Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Oncology Drug Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Drugs used for oncology.
In 2019, the market size of Oncology Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Oncology Drug.

This report studies the global market size of Oncology Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Oncology Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Roche Ltd
Novartis AG
Bristol-Myers Squibb
Celgene Corporation
Johnson & Johnson
Pfizer Inc.
Astra Zenca Plc
Eli Lilly And Company.
Glaxosmithkline Plc
Merck & Co.
Sanofi
Amgen Inc.
Abbvie

Market Segment by Product Type
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy
Others

Market Segment by Application
Blood Cancer
Breast Cancer
gastrointestinal Tract Cancer
Prostate Cancer
Lung Cancer
Skin Cancer

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Oncology Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Oncology Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Oncology Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025